Specialty Pharmacy Continuum

The “patient as payor” model is breaking down care access. 💊 $60B+ in out-of-pocket pharmacy spend (2024) 📉 Up to 60% prescription abandonment at high costs Read more: specialtypharmacycontinuum.com/a/qjkBAA/t #pharmacy #AXS25

Can genetics help predict opioid risk after surgery? NEW algorithm combining genetic + clinical factors may better identify patients at risk for pain + opioid-related complications after lumbar spine surgery: specialtypharmacycontinuum.com/a/CDoBAA/t #painmedicine

Pharmacist-led care = measurable impact 📊 In inflammatory disease patients: • Pain ↓ (2.9 → 1.8) • Flares ↓ (2.6 → 0.8) • 62% of RA patients improved severity The value of pharmacist integration: specialtypharmacycontinuum.com/a/qDkBAA/t #pharmacy

IVIG isn’t one-size-fits-all in transplant care. From AMR treatment to desensitization, its role depends on the context—and the combo. Here’s where it adds value 👇 specialtypharmacycontinuum.com/a/pzkBAA/t #IVIG #pharmacy

Can AI cut specialty drug costs? 🤖💊 One PBM used AI to route prescriptions to the lowest-cost pharmacy—saving $1.73M on just 10 drugs. But… at what cost to patient care? specialtypharmacycontinuum.com/a/RDkBAA/t #SpecialtyPharmacy #AI

A simple tech upgrade, a major impact 👇 Smart speakers helped cut NICU medication delivery times to under 10 minutes—when every second counts: specialtypharmacycontinuum.com/a/vjkBAA/t #NICU

Getting into PBM networks is just the start. Getting paid—and paid fairly—is the real battle. New insights on how home infusion providers can push back 👇 specialtypharmacycontinuum.com/a/ojkBAA/t #PBM #pharmacy #NHIA

GLP-1s are booming—but are patients staying on them? 📉 Real-world persistence at 3 years: just 8.1% What’s driving drop-off—and what can pharmacy do about it? 👇 specialtypharmacycontinuum.com/a/qTkBAA/t #GLP1 #Pharmacy #AMCPNexus

@nationaltardive TD impacts more than movement—patients say anxiety, shame & social isolation hit hardest. Physicians see physical & emotional effects more evenly: specialtypharmacycontinuum.com/a/rjgBAA/t #TardiveDyskinesia #PatientVoice #MentalHealth

GLP-1s + oncology = unanswered questions. @HOPArx Cancer risk signals? Mixed. Drug interactions? Possible. Guidance? Limited. Clinicians are navigating this in real time: specialtypharmacycontinuum.com/a/sDgBAA/t #GLP1 #oncology #HOPA2026

Oncology Rx abandonment: 📦 Mail order/national avg: ~18% 🏥 Medically integrated pharmacy: <1% Same meds—very different outcomes: specialtypharmacycontinuum.com/a/SToBAA/t #Oncology #AXS26 #pharmacy

$60 BILLION in out-of-pocket Rx costs. 9% of prescriptions abandoned. 60% when cost hits $500+. The “patient as payor” model isn’t working. 👇 specialtypharmacycontinuum.com/a/qjkBAA/t #AXS25 #pharmacy

High-dose opioids in cancer survivors: 💰 Higher costs 📉 Worse outcomes New data raises important questions about long-term use. More 👇 specialtypharmacycontinuum.com/a/pjkBAA/t #Oncology #OpioidStewardship

There are ~7,000 rare diseases—but <10% have an approved treatment. Real-world evidence (RWE) could help close that gap. 💊: specialtypharmacycontinuum.com/a/PDoBAA/t #RareDisease #RWE

Working with PAPs? It’s not one-size-fits-all. Charitable vs manufacturer programs have very different requirements—and missing details can delay access or put grants at risk. 💊: specialtypharmacycontinuum.com/a/7zkBAA/t #SpecialtyPharmacy

Low-FODMAP diet in IBS: helpful tool or potential risk? Experts debate symptom relief vs risk of reinforcing disordered eating patterns: specialtypharmacycontinuum.com/a/gDkBAA/t #IBS #Gastroenterology

Theranostics is reshaping oncology pharmacy 🔥 @HOPArx Radiopharmaceuticals like lutetium Lu 177 vipivotide tetraxetan are driving innovation—but access + infrastructure remain major barriers: specialtypharmacycontinuum.com/a/mDgBAA/t #Oncology #NuclearMedicine #HOPA2026

A pharmacogenetic algorithm designed to predict opioid and pain risks after surgery may also have economic upside. The next step? Proving value at scale—and navigating access to genotyping: specialtypharmacycontinuum.com/a/CDoBAA/t #painmedicine #pharmacy

Can we predict who will struggle with pain—or opioids—after spine surgery? New research suggests genetics + clinical data may hold the answer 👇 specialtypharmacycontinuum.com/a/CDoBAA/t #opioid #lumbarsurgery

May is Hepatitis Awareness Month 💛 Millions live with hepatitis without knowing it. Testing can save lives. #HepatitisAwarenessMonth #Hepatitis